BioPhenoMA enters into MOU with Taiwan Exosome Inc. and Waseda University for international collaboration on the analysis of NK cell-derived exosomes.(Nikkei Biotechnology & Business)
BioPhenoMA (Shinjuku, Tokyo, Japan), a company developing instruments capable of detecting ultra-trace amounts of proteins, announced on July 2, 2026, that it has signed a Memorandum of Understanding (MOU) with Taiwan Exosome, a Taiwanese startup, and Waseda University to promote international collaboration in the discovery of novel biomarkers utilizing exosomes. Through this partnership, the three parties aim to develop innovative diagnostic technologies based on research into immune cell-derived exosomes while further strengthening international research collaboration.